Global Regenerative Group Becomes Global Partner for Pharmaceutical Wholesaler Prosupplier GmbH Representing Their CureOs® Synthetic BONE GRAFT

Boca Raton, FL, August 02, 2019 --(PR.com)-- Of the agreement, Prosupplier’s General Manager, Sibel Peksen said, “We are excited to work with Global Regenerative Group, as we see in them a credible company with big future in both business and science. Our main aim is to create a network between companies, helping each other to develop health care around the world.” The partnership of the two companies will provide a globally accessible international market. This way, CureOs® Synthetic BONE GRAFT will be able to reach more physicians around the world.

"My long experience with implementation of regenerative therapies in medical practice granted me the chance to notice that there is a great dissent in the medical practice and science. I have encountered problems like lack of evidence of effectiveness about certain therapies, creating false claims on the product labels, and so on. That’s the reason why partnership of the two companies is so important for us. I think, working together, we will develop a successful business, solving these problems of our society,” states Mihail Blagoev, Vice President of Global Regenerative Group.

CureOs® Synthetic BONE GRAFT
CureOs -TriCalcium Phosphate/Silicate Bone Grafts are synthetic, osteoconductive, 80% porous, interconnected macroporosity and microporosity structured, resorbable and biologically compatible bone graft substitute materials. It provides major help for bone healing process.

CureOs - TriCalcium Phosphate/Silicate Bone Grafts are used in:

General bone defects repairment, metaphysical defects repairment, reconstruction, augmentation and filling maxillofacial region, arthrodesis and benign tumor treatment, spinal defects repairmen, sinus rifts, filling of endodontic defects, ridge augmentation, cavity filling in bone tissue.

CureOs has an 80% porosity which enhances osteoconductivity. Micro-porosity acts as an attracting agent to bone generating cells, which allows bone formation inside the granule. Macro-porosity promotes the invasion of osteogenic cells by osteoconduction.

Silicate used in the CureOs, accelerates the bone formation and provides a more stable osteoconductive scaffold. Silicate is essential for normal bone development and its level in a bone graft has a positive effect on the healing process. CureOs Synthetic bone grafts are manufactured from Beta Tricalcium Phosphate and is absent from any cytotoxic effects.

About Global Regenerative Group
The company provides business development for medical device companies with an emphasis on Regenerative Medicine technologies and works extensively with clinics, hospitals and medical facilities that are engaged in Regenerative Therapy.

Regenerative medicine is a new, evidence based, multidisciplinary approach that seeks to repair or replace damaged or diseased human cells or tissues to restore normal function, which holds the promise of revolutionizing patient care in the 21st century.

Global Regenerative Group was established to share groundbreaking medical technologies for use in therapies that significantly enhance the body’s natural healing ability. During the last decade the company has developed extensive experience in the most advanced medical device industries. In the past several years, the company's emphasis has been focused exclusively on Regenerative Medicine, such as stem cell technologies, products, and therapies.

Global Regenerative Group consults with science based and reputed medical technology companies that are startups and/or companies looking to expand and grow their business. Global Regenerative Group has built a comprehensive network of experts in Europe, South America, Middle East, Asia and Australia. The company also organizes and facilitates scientific conferences and workshops to lecture about the latest developments, innovations, and breakthroughs.

About Prosupplier
Prosupplier GmbH is a pharmaceutical wholesaler located in Basel and established in 2014. They are holding a licence for Swissmedic and they perform import and export of pharmaceuticals, cosmetics.

Even though they are a young company, thanks to their experienced and specialist team they have gained a place in the international pharmaceutical market in a short span of time. As a Swiss company, quality is very important for them. Their company complies with "Good Distribution Practices." Even though they have access to many pharmaceuticals markets around the world, they are working hard to reach more and more in order to supply all needed products at competitive price in the shortest time.